Targeting the nerve growth factor network in Alzheimer’s disease

Author： Sykiotis Gerasimos P Papavassiliou Athanasios G

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.16, Iss.3, 2007-03, pp. : 267-269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oestrogen and nerve growth factor – neuroprotection and repair in Alzheimer’s disease

By Granholm A-C.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 685-694

Informa Healthcare

Access to resources Recommend Favorite

Nerve Growth Factor: Structure, Function and Therapeutic Implications for Alzheimer's Disease

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 5, 2003-10 ,pp. : 315-334

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting insulin-like growth factor-1 to treat Alzheimer's disease

By Torres-Aleman Ignacio

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 12, 2007-12 ,pp. : 1535-1542

Informa Healthcare

Access to resources Recommend Favorite

Targeting NO/cGMP Signaling in the CNS for Neurodegeneration and Alzheimer’s Disease

Current Medicinal Chemistry, Vol. 23, Iss. 24, 2016-07 ,pp. : 2770-2788

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Human Astrocytes' Calcium-sensing Receptors for Treatment of Alzheimer's Disease

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 4990-5000

Bentham Science Publishers

Access to resources Recommend Favorite